Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Unternehmen & Branche
| Name | Alphatec Holdings, Inc. |
|---|---|
| Ticker | ATEC |
| CIK | 0001350653 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 1,42 Mrd. USD |
| Beta | 1,12 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -143,358,000 | -0.96 | 791,208,000 | 12,426,000 | |
| 2025-09-30 | 10-Q | -28,578,000 | -0.19 | 787,248,000 | 11,506,000 | |
| 2025-06-30 | 10-Q | -41,144,000 | -0.27 | 790,293,000 | 23,771,000 | |
| 2025-03-31 | 10-Q | -51,907,000 | -0.35 | 785,473,000 | -85,939,000 | |
| 2024-12-31 | 10-K | -162,123,000 | -1.13 | 775,710,000 | -14,169,000 | |
| 2024-09-30 | 10-Q | -39,616,000 | -0.28 | 745,895,000 | -1,362,000 | |
| 2024-06-30 | 10-Q | -40,680,000 | -0.29 | 768,586,000 | 17,111,000 | |
| 2024-03-31 | 10-Q | -48,495,000 | -0.34 | 774,581,000 | 37,552,000 | |
| 2023-12-31 | 10-K | -186,638,000 | -1.54 | 805,208,000 | 78,116,000 | |
| 2023-09-30 | 10-Q | -42,654,000 | -0.35 | 670,221,000 | -44,161,000 | |
| 2023-06-30 | 10-Q | -51,377,000 | -0.43 | 628,234,000 | -28,153,000 | |
| 2023-03-31 | 10-Q | -43,529,000 | -0.40 | 569,693,000 | -58,362,000 | |
| 2022-12-31 | 10-K | -151,293,000 | -1.46 | 520,968,000 | -34,667,000 | |
| 2022-09-30 | 10-Q | -36,793,000 | -0.35 | 516,283,000 | -20,894,000 | |
| 2022-06-30 | 10-Q | -37,101,000 | -0.36 | 511,935,000 | 12,115,000 | |
| 2022-03-31 | 10-Q | -42,616,000 | -0.43 | 548,689,000 | 43,440,000 | |
| 2021-12-31 | 10-K | -143,032,000 | -1.49 | 572,053,000 | 80,674,000 | |
| 2021-09-30 | 10-Q | -43,031,000 | -0.43 | 598,108,000 | 111,757,000 | |
| 2021-06-30 | 10-Q | -38,205,000 | -0.39 | 441,027,000 | 213,514,000 | |
| 2021-03-31 | 10-Q | -22,903,000 | 404,503,000 | 108,292,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -260,535 | 12.30 | -3,204,580.50 | -224,2% | |
| 2026-03-13 | Koning John Todd | Officer, CHIEF FINANCIAL OFFICER | Open Market Sale | -79,789 | 12.36 | -986,192.04 | -69,0% | |
| 2026-03-09 | Hunsaker Craig E | Officer, EVP, PEOPLE & CULTURE | Open Market Sale | -82,765 | 12.45 | -1,030,424.25 | -72,1% | |
| 2026-03-06 | Hunsaker Craig E | Officer, EVP, PEOPLE & CULTURE | Open Market Sale | -33,602 | 12.22 | -410,616.44 | -28,7% | |
| 2026-03-05 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -88,835 | 12.49 | -1,109,549.15 | -77,6% | |
| 2026-02-05 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -60,425 | 13.79 | -833,260.75 | -58,3% | |
| 2026-02-03 | Hunsaker Craig E | Officer, EVP, PEOPLE & CULTURE | Open Market Sale | -37,358 | 14.71 | -549,536.18 | -38,4% | |
| 2026-01-05 | Miles Patrick | Director, Officer, CEO | Open Market Sale | -100,000 | 21.01 | -2,101,000.00 | -147,0% | |
| 2025-12-16 | Pelizzon David R | Director | Open Market Sale | -250,000 | 19.66 | -4,915,000.00 | -343,9% | |
| 2025-12-16 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -19,900 | 19.64 | -390,836.00 | -27,3% | |
| 2025-12-11 | Demski David M | Director | Open Market Sale | -30,000 | 21.20 | -636,000.00 | -44,5% | |
| 2025-12-10 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -21,106 | 20.79 | -438,793.74 | -30,7% | |
| 2025-12-10 | Hunsaker Craig E | Officer, EVP, PEOPLE & CULTURE | Open Market Sale | -32,584 | 20.84 | -679,050.56 | -47,5% | |
| 2025-12-09 | Pelizzon David R | Director, 10% Owner | Open Market Sale | -28,834 | 21.03 | -606,379.02 | -42,4% | |
| 2025-12-09 | Squadron Capital LLC | 10% Owner | Open Market Sale | -28,834 | 21.03 | -606,379.02 | -42,4% | |
| 2025-12-08 | Pelizzon David R | Director, 10% Owner | Open Market Sale | -221,166 | 21.20 | -4,688,719.20 | -328,0% | |
| 2025-12-08 | Squadron Capital LLC | 10% Owner | Open Market Sale | -221,166 | 21.20 | -4,688,719.20 | -328,0% | |
| 2025-12-08 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -988 | 21.45 | -21,192.60 | -1,5% | |
| 2025-12-05 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -10,875 | 21.47 | -233,486.25 | -16,3% | |
| 2025-12-05 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -12,965 | 21.47 | -278,358.55 | -19,5% | |
| 2025-12-05 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -9,924 | 21.48 | -213,167.52 | -14,9% | |
| 2025-12-01 | Miles Patrick | Director, Officer, CEO | Open Market Sale | -100,000 | 22.11 | -2,211,000.00 | -154,7% | |
| 2025-11-24 | Pelizzon David R | Director, 10% Owner | Open Market Sale | -250,000 | 20.62 | -5,155,000.00 | -360,7% | |
| 2025-11-24 | Squadron Capital LLC | 10% Owner | Open Market Sale | -250,000 | 20.62 | -5,155,000.00 | -360,7% | |
| 2025-11-20 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -25,000 | 19.80 | -495,000.00 | -34,6% | |
| 2025-11-20 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -70,000 | 19.51 | -1,365,700.00 | -95,5% | |
| 2025-11-12 | Squadron Capital LLC | 10% Owner | Open Market Sale | -250,000 | 20.80 | -5,200,000.00 | -363,8% | |
| 2025-11-12 | Pelizzon David R | Director, 10% Owner | Open Market Sale | -250,000 | 20.80 | -5,200,000.00 | -363,8% | |
| 2025-11-03 | Rydin Jeffrey P | Director | Open Market Sale | -200,000 | 19.32 | -3,864,000.00 | -270,3% | |
| 2025-11-03 | Miles Patrick | Director, Officer, CEO | Open Market Sale | -100,000 | 18.96 | -1,896,000.00 | -132,6% | |
| 2025-10-31 | Hunsaker Craig E | Officer, EVP, PEOPLE & CULTURE | Open Market Sale | -100,000 | 19.95 | -1,995,000.00 | -139,6% | |
| 2025-10-24 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -70,000 | 16.18 | -1,132,600.00 | -79,2% | |
| 2025-10-01 | Miles Patrick | Director, Officer, CEO | Open Market Sale | -100,000 | 13.96 | -1,396,000.00 | -97,7% | |
| 2025-09-19 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -2,555 | 15.34 | -39,193.70 | -2,7% | |
| 2025-09-18 | Sponsel David | Officer, EVP, SALES | Open Market Sale | -137,445 | 15.09 | -2,074,045.05 | -145,1% | |
| 2025-08-21 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -6,323 | 16.01 | -101,231.23 | -7,1% | |
| 2025-08-13 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -9,302 | 16.00 | -148,832.00 | -10,4% | |
| 2025-08-05 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -9,924 | 14.86 | -147,470.64 | -10,3% | |
| 2025-08-05 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -8,168 | 14.96 | -122,193.28 | -8,5% | |
| 2025-08-05 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -16,666 | 15.00 | -249,990.00 | -17,5% | |
| 2025-08-04 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -17,857 | 14.00 | -249,998.00 | -17,5% | |
| 2025-08-01 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -12,878 | 12.00 | -154,536.00 | -10,8% | |
| 2025-08-01 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -36,081 | 12.53 | -452,094.93 | -31,6% | |
| 2025-07-10 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -3,982 | 12.00 | -47,784.00 | -3,3% | |
| 2025-07-10 | Marshall Tyson Eliot | Officer, GENERAL COUNSEL & CORP. SEC. | Open Market Sale | -1,500 | 12.00 | -18,000.00 | -1,3% | |
| 2025-06-13 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -22,727 | 11.07 | -251,587.89 | -17,6% | |
| 2025-05-19 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -55,375 | 13.00 | -719,875.00 | -50,4% | |
| 2025-05-05 | Lish Scott | Officer, CHIEF OPERATING OFFICER | Open Market Sale | -12,000 | 12.12 | -145,440.00 | -10,2% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.